141 related articles for article (PubMed ID: 20797954)
1. Conditions and consequences of a BRCA mutation in young, single women of childbearing age.
Hamilton R; Hurley KE
Oncol Nurs Forum; 2010 Sep; 37(5):627-34. PubMed ID: 20797954
[TBL] [Abstract][Full Text] [Related]
2. Being young, female, and BRCA positive.
Hamilton R
Am J Nurs; 2012 Oct; 112(10):26-31, quiz 46, 32. PubMed ID: 22982855
[TBL] [Abstract][Full Text] [Related]
3. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
4. Beating the biological clock: the compressed family life cycle of young women with BRCA gene alterations.
Werner-Lin A
Soc Work Health Care; 2008; 47(4):416-37. PubMed ID: 19042494
[TBL] [Abstract][Full Text] [Related]
5. How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults.
Bradbury AR; Dignam JJ; Ibe CN; Auh SL; Hlubocky FJ; Cummings SA; White M; Olopade OI; Daugherty CK
J Clin Oncol; 2007 Aug; 25(24):3705-11. PubMed ID: 17704419
[TBL] [Abstract][Full Text] [Related]
6. 'Cancer doesn't have an age': genetic testing and cancer risk management in BRCA1/2 mutation-positive women aged 18-24.
Werner-Lin A; Hoskins LM; Doyle MH; Greene MH
Health (London); 2012 Nov; 16(6):636-54. PubMed ID: 22547552
[TBL] [Abstract][Full Text] [Related]
7. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.
Hallowell N; Foster C; Eeles R; Ardern-Jones A; Watson M
Soc Sci Med; 2004 Aug; 59(3):553-65. PubMed ID: 15144764
[TBL] [Abstract][Full Text] [Related]
8. Educational-support groups for BRCA mutation carriers satisfy need for information but do not affect emotional distress.
Landsbergen KM; Brunner HG; Manders P; Hoogerbrugge N; Prins JB
Genet Couns; 2010; 21(4):423-37. PubMed ID: 21290972
[TBL] [Abstract][Full Text] [Related]
9. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
10. Theory development from studies with young women with breast cancer who are BRCA mutation negative.
Hamilton R; Kopin S
ANS Adv Nurs Sci; 2013; 36(2):E41-53. PubMed ID: 23644270
[TBL] [Abstract][Full Text] [Related]
11. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
[TBL] [Abstract][Full Text] [Related]
12. "It's not if I get cancer, it's when I get cancer": BRCA-positive patients' (un)certain health experiences regarding hereditary breast and ovarian cancer risk.
Dean M
Soc Sci Med; 2016 Aug; 163():21-7. PubMed ID: 27376595
[TBL] [Abstract][Full Text] [Related]
13. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
[TBL] [Abstract][Full Text] [Related]
14. [Having a child and PND/PGD access in women with a BRCA1/2 mutation? Different approach whether ill or healthy].
Pellegrini I; Prodromou N; Coupier I; Huiart L; Moretta J; Noguès C; Julian-Reynier C
Bull Cancer; 2014 Nov; 101(11):1001-8. PubMed ID: 25418592
[TBL] [Abstract][Full Text] [Related]
15. Five families living with hereditary breast and ovarian cancer risk.
Norris J; Spelic SS; Snyder C; Tinley S
Clin J Oncol Nurs; 2009 Feb; 13(1):73-80. PubMed ID: 19193551
[TBL] [Abstract][Full Text] [Related]
16. A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations.
Esplen MJ; Hunter J; Leszcz M; Warner E; Narod S; Metcalfe K; Glendon G; Butler K; Liede A; Young MA; Kieffer S; DiProspero L; Irwin E; Wong J
Cancer; 2004 Nov; 101(10):2327-40. PubMed ID: 15478194
[TBL] [Abstract][Full Text] [Related]
17. Toward a new understanding of risk perception among young female BRCA1/2 "previvors".
Hoskins LM; Roy KM; Greene MH
Fam Syst Health; 2012 Mar; 30(1):32-46. PubMed ID: 22429077
[TBL] [Abstract][Full Text] [Related]
18. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Kauff ND; Satagopan JM; Robson ME; Scheuer L; Hensley M; Hudis CA; Ellis NA; Boyd J; Borgen PI; Barakat RR; Norton L; Castiel M; Nafa K; Offit K
N Engl J Med; 2002 May; 346(21):1609-15. PubMed ID: 12023992
[TBL] [Abstract][Full Text] [Related]
19. Decision-making process of women carrying a BRCA1 or BRCA2 mutation who have chosen prophylactic mastectomy.
McQuirter M; Castiglia LL; Loiselle CG; Wong N
Oncol Nurs Forum; 2010 May; 37(3):313-20. PubMed ID: 20439215
[TBL] [Abstract][Full Text] [Related]
20. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
Kuschel B; Lux MP; Goecke TO; Beckmann MW
Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
